{
    "2019-02-05": [
        [
            {
                "time": "2019-02-05",
                "original_text": "Dow Rallies For Second Straight Triple-Digit Win",
                "features": {
                    "keywords": [
                        "Dow",
                        "Rallies",
                        "Triple-Digit",
                        "Win"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Market Close Report: NASDAQ Composite index closes at 7,402.08 up 54.54 points",
                "features": {
                    "keywords": [
                        "NASDAQ",
                        "Composite",
                        "closes",
                        "up",
                        "points"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Merck CEO Frazier to testify at Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "Merck",
                        "CEO",
                        "Frazier",
                        "testify",
                        "Senate",
                        "drug",
                        "pricing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Pharma execs will testify before Congress 'one way or another,' US senator says",
                "features": {
                    "keywords": [
                        "Pharma",
                        "execs",
                        "testify",
                        "Congress",
                        "US",
                        "senator"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Incyte",
                        "Olumiant",
                        "Eczema",
                        "Studies"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "OPGN",
                        "CNC",
                        "GILD",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Corporate Profits' New Enemy Is the 'Dollar Vortex'",
                "features": {
                    "keywords": [
                        "Corporate",
                        "Profits",
                        "Enemy",
                        "Dollar",
                        "Vortex"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-05",
                "original_text": "Here's Why Exact Sciences Soared 42.8% in January",
                "features": {
                    "keywords": [
                        "Exact",
                        "Sciences",
                        "Soared",
                        "January"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}